Digital FH25: On the future of health, with Frontiers Health Chairma... In the final episode of our special Frontiers Health limited series, conference Chairman Roberto Ascione discusses his favourite moments and insights.
Digital Anthropy23, part one: The future of AI, the future of Britai... The convergence of brilliant minds that is Anthropy returned to Cornwall’s Eden Project last week, bringing together experts from diverse fields to foster fresh thinking and spark innovatio
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.